Dec 13 (Reuters) - Sigma Healthcare Ltd SIG.AX :
* ANTICIPATED FY20 EBITDA OF APPROXIMATELY $46 MLN-47 MLN
* GROWTH THROUGH FY21 IS EXPECTED TO ACCELERATE FROM BOTH CORE BUSINESS AND MC/CW GROUP
* SIGMA HEALTHCARE-NEW FIRST-LINE AGREEMENT WITH MY CHEMIST WILL RESULT IN CO ANNUALISED SALES RISING BY $700 - $800 MILLION AT FULL RUN RATE